cytosine drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (10)
Papers in which this entity is mentioned.
- The repertoire of mutational signatures in human cancer. (2020)
- Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes. (2020)
- Sequence, Structure, and Context Preferences of Human RNA Binding Proteins. (2018)
- A compendium of conserved cleavage and polyadenylation events in mammalian genes. (2018)
- Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. (2016)
- Three decades of nanopore sequencing. (2016)
- APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. (2016)
- Compression of FASTQ and SAM format sequencing data. (2013)
- Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. (2012)
- ViennaRNA Package 2.0. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cytosine | drug | 21 | 27 |